A convergent synthetic platform for dual anticancer drugs functionalized by reduced graphene nanocomposite delivery for hepatocellular cancer

References

• Abu Lila AS, Soliman MS, Kiran HC, et al. (2021). Tamoxifen-loaded functionalized graphene nanoribbons for breast cancer therapy. J Drug Deliv Sci Technol 63:102499.
   Web of Science ®Google Scholar
• Ahn H-M, Ryu J, Song JM, et al. (2017). Anti-cancer activity of novel TM4SF5-targeting antibodies through TM4SF5 neutralization and immune cell-mediated cytotoxicity. Theranostics 7:594–613.
   PubMed Web of Science ®Google Scholar
• Alemi F, Zarezadeh R, Sadigh AR, et al. (2020). Graphene oxide and reduced graphene oxide: efficient cargo platforms for cancer theranostics. J Drug Deliv Sci Technol 60:101974.
   Web of Science ®Google Scholar
• Azerbaijan MH, Bahmani E, Jouybari MH, et al. (2021). Electrospun gold nanorods/graphene oxide loaded-core-shell nanofibers for local delivery of paclitaxel against lung cancer during photo-chemotherapy method. Eur J Pharm Sci 164:105914.
   PubMed Web of Science ®Google Scholar
• Balaji S, Mohamed Subarkhan MK, Ramesh R, et al. (2020). Synthesis and structure of arene Ru(II) N∧O-chelating complexes: in vitro cytotoxicity and cancer cell death mechanism. Organometallics 39:1366–75.
   Web of Science ®Google Scholar
• Biju V. (2014). Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy. Chem Soc Rev 43:744–64.
   PubMed Web of Science ®Google Scholar
• Brar G, Greten TF, Graubard BI, et al. (2020). Hepatocellular carcinoma survival by etiology: a SEER-medicare database analysis. Hepatol Commun 4:1541–51.
   PubMed Web of Science ®Google Scholar
• Broza YY, Vishinkin R, Barash O, et al. (2018). Synergy between nanomaterials and volatile organic compounds for non-invasive medical evaluation. Chem Soc Rev 47:4781–859.
   PubMed Web of Science ®Google Scholar
• Campbell E, Hasan MT, Gonzalez-Rodriguez R, et al. (2021). Graphene quantum dot formulation for cancer imaging and redox-based drug delivery. Nanomedicine 102408.doi: 10.1016/j.nano.2021.102408.
   PubMed Web of Science ®Google Scholar
• Chang L, Hou Y, Zhu L, et al. (2020). Veliparib overcomes multidrug resistance in liver cancer cells. Biochem Biophys Res Commun 521:596–602.
   PubMed Web of Science ®Google Scholar
• Chen H, Shi D, Wang Y, et al. (2015). The advances in applying inorganic fluorescent nanomaterials for the detection of hepatocellular carcinoma and other cancers. RSC Adv 5:79572–84.
   Web of Science ®Google Scholar
• Chen Y-C, Chiu W-T, Chen J-C, et al. (2015). The photothermal effect of silica-carbon hollow sphere-concanavalin A on liver cancer cells. J Mater Chem B 3:2447–54.
   PubMed Web of Science ®Google Scholar
• Chi X, Liu K, Luo X, et al. (2020). Recent advances of nanomedicines for liver cancer therapy. J Mater Chem B 8:3747–71.
   PubMed Web of Science ®Google Scholar
• Della Corte CM, Ciaramella V, Mauro CD, et al. (2016). Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells. Oncotarget 7:4265–78.
   PubMedGoogle Scholar
• Dolatkhah M, Hashemzadeh N, Barar J, et al. (2020). Graphene-based multifunctional nanosystems for simultaneous detection and treatment of breast cancer. Colloids Surf B Biointerfaces 193:111104.
   PubMed Web of Science ®Google Scholar
• Evans JMM, Donnelly LA, Emslie-Smith AM, et al. (2005). Metformin and reduced risk of cancer in diabetic patients. BMJ 330:1304–5.
   PubMed Web of Science ®Google Scholar
• Fan N, Li P, Wu C, et al. (2021). ALP-activated chemiluminescence PDT nano-platform for liver cancer-specific theranostics. ACS Appl Bio Mater 4:1740–8.
   PubMedGoogle Scholar
• Guo X, Shao X, Li J, et al. (2019). Fruit and vegetable intake and liver cancer risk: a meta-analysis of prospective cohort studies. Food Funct 10:4478–85.
   PubMed Web of Science ®Google Scholar
• Han H, Wang L, Liu Y, et al. (2019). Combination of curcuma zedoary and kelp inhibits growth and metastasis of liver cancer in vivo and in vitro via reducing endogenous H2S levels. Food Funct 10:224–34.
   PubMed Web of Science ®Google Scholar
• Hlady RA, Zhao X, Pan X, et al. (2019). Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA. Theranostics 9:7239–50.
   PubMed Web of Science ®Google Scholar
• Hu D, Zhang J, Gao G, et al. (2016). Indocyanine green-loaded polydopamine-reduced graphene oxide nanocomposites with amplifying photoacoustic and photothermal effects for cancer theranostics. Theranostics 6:1043–52.
   PubMed Web of Science ®Google Scholar
• Huang D, Dai H, Tang K, et al. (2020). A versatile UCST-type composite microsphere for image-guided chemoembolization and photothermal therapy against liver cancer. Nanoscale 12:20002–15.
   PubMed Web of Science ®Google Scholar
• Johnson JA, Majumdar SR, Simpson SH, Toth EL. (2002). Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care 25:2244–8.
   PubMed Web of Science ®Google Scholar
• Karki N, Tiwari H, Tewari C, et al. (2020). Functionalized graphene oxide as a vehicle for targeted drug delivery and bioimaging applications. J Mater Chem B 8:8116–48.
   PubMed Web of Science ®Google Scholar
• Kazantseva J, Ivanov R, Gasik M, et al. (2018). Graphene-augmented nanofiber scaffolds trigger gene expression switching of four cancer cell types. ACS Biomater Sci Eng 4:1622–9.
   PubMed Web of Science ®Google Scholar
• Keisham B, Cole A, Nguyen P, et al. (2016). Cancer cell hyperactivity and membrane dipolarity monitoring via raman mapping of interfaced graphene: toward non-invasive cancer diagnostics. ACS Appl Mater Interfaces 8:32717–22.
   PubMed Web of Science ®Google Scholar
• Kim J, Lee S, Na K. (2021). Glycyrrhetinic acid-modified silicon phthalocyanine for liver cancer-targeted photodynamic therapy. Biomacromolecules 22:811–22.
   PubMed Web of Science ®Google Scholar
• Krishnan SK, Singh E, Singh P, et al. (2019). A review on graphene-based nanocomposites for electrochemical and fluorescent biosensors. RSC Adv 9:8778–881.
   PubMed Web of Science ®Google Scholar
• Lai H, Xu F, Zhang Y, Wang L. (2018). Recent progress on graphene-based substrates for surface-enhanced Raman scattering applications. J Mater Chem B 6:4008–28.
   PubMed Web of Science ®Google Scholar
• Lee MH, Kim E-J, Lee H, et al. (2016). Liposomal texaphyrin theranostics for metastatic liver cancer. J Am Chem Soc 138:16380–7.
   PubMed Web of Science ®Google Scholar
• Li J, Hu S, Zhang Z, et al. (2020). LASP2 is downregulated in human liver cancer and contributes to hepatoblastoma cell malignant phenotypes through MAPK/ERK pathway. Biomed Pharmacother 127:110154.
   PubMed Web of Science ®Google Scholar
• Li M, Bu W, Ren J, et al. (2018). Enhanced synergism of thermo-chemotherapy for liver cancer with magnetothermally responsive nanocarriers. Theranostics 8:693–709.
   PubMed Web of Science ®Google Scholar
• Li Q, Wen J, Liu C, et al. (2019). Graphene-nanoparticle-based self-healing hydrogel in preventing postoperative recurrence of breast cancer. ACS Biomater Sci Eng 5:768–79.
   PubMed Web of Science ®Google Scholar
• Lin K-C, Lin M-W, Hsu M-N, et al. (2018). Graphene oxide sensitizes cancer cells to chemotherapeutics by inducing early autophagy events, promoting nuclear trafficking and necrosis. Theranostics 8:2477–87.
   PubMed Web of Science ®Google Scholar
• Liu Y, Bhattarai P, Dai Z, Chen X. (2019). Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev 48:2053–108.
   PubMed Web of Science ®Google Scholar
• Lo P-Y, Lee G-Y, Zheng J-H, et al. (2020). GFP plasmid and chemoreagent conjugated with graphene quantum dots as a novel gene delivery platform for colon cancer inhibition in vitro and in vivo. ACS Appl Bio Mater 3:5948–56.
   PubMedGoogle Scholar
• Lu H, Zhang H, Xiao Y, et al. (2020). Comparative study of alterations in phospholipid profiles upon liver cancer in humans and mice. Analyst 145:6470–7.
   PubMed Web of Science ®Google Scholar
• Mallick A, Nandi A, Basu S. (2019). Polyethylenimine coated graphene oxide nanoparticles for targeting mitochondria in cancer cells. ACS Appl Bio Mater 2:14–9.
   PubMedGoogle Scholar
• Mohamed Kasim MS, Sundar S, Rengan R. (2018). Synthesis and structure of new binuclear ruthenium(ii) arene benzil bis(benzoylhydrazone) complexes: investigation on antiproliferative activity and apoptosis induction. Inorg Chem Front 5:585–96.
   Web of Science ®Google Scholar
• Mohamed Subarkhan MK, Ramesh R, Liu Y. (2016). Synthesis and molecular structure of arene ruthenium(II) benzhydrazone complexes: impact of substitution at the chelating ligand and arene moiety on antiproliferative activity. New J Chem 40:9813–23.
   Web of Science ®Google Scholar
• Mohamed Subarkhan MK, Ren L, Xie B, et al. (2019). Novel tetranuclear ruthenium(II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo. Eur J Med Chem 179:246–56.
   PubMed Web of Science ®Google Scholar
• Mora MI, Molina M, Odriozola L, et al. (2017). Prioritizing popular proteins in liver cancer: remodelling one-carbon metabolism. J Proteome Res 16:4506–14.
   PubMed Web of Science ®Google Scholar
• Morgillo F, Fasano M, Della Corte CM, et al. (2017). Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer. ESMO Open 2:e000132.
   PubMed Web of Science ®Google Scholar
• Nanda SS, Kaushal S, Shin Y, et al. (2021). Cancer cell detection on the surface of top-gated monolayer graphene via raman spectroscopy. ACS Appl Bio Mater 4:1493–8.
   PubMedGoogle Scholar
• Nurunnabi M, Parvez K, Nafiujjaman M, et al. (2015). Bioapplication of graphene oxide derivatives: drug/gene delivery, imaging, polymeric modification, toxicology, therapeutics and challenges. RSC Adv 5:42141–61.
   Web of Science ®Google Scholar
• Park H-G, Jang K-S, Park H-M, et al. (2019). MALDI-TOF MS-based total serum protein fingerprinting for liver cancer diagnosis. Analyst 144:2231–8.
   PubMed Web of Science ®Google Scholar
• Perumal S, Gangadaran P, Bae YW, et al. (2021). Noncovalent functionalized graphene nanocarriers from graphite for treating thyroid cancer cells. ACS Biomater Sci Eng 7:2317–28.
   PubMed Web of Science ®Google Scholar
• Raja G, Selvaraj V, Suk M, et al. (2021). Metabolic phenotyping analysis of graphene oxide nanosheets exposures in breast cancer cells: metabolomics profiling techniques. Process Biochem 104:39–45.
   Web of Science ®Google Scholar
• Sathiya Kamatchi T, Mohamed Subarkhan MK, Ramesh R, et al. (2020). Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes. Dalton Trans 49:11385–95.
   PubMed Web of Science ®Google Scholar
• Shangguan D, Meng L, Cao ZC, et al. (2008). Identification of liver cancer-specific aptamers using whole live cells. Anal Chem 80:721–8.
   PubMed Web of Science ®Google Scholar
• Shekari Z, Zare HR, Falahati A. (2021). Dual assaying of breast cancer biomarkers by using a sandwich–type electrochemical aptasensor based on a gold nanoparticles–3D graphene hydrogel nanocomposite and redox probes labeled aptamers. Sensors Actuators B Chem 332:129515.
   Web of Science ®Google Scholar
• Shen H, Zhang L, Liu M, Zhang Z. (2012). Biomedical applications of graphene. Theranostics 2:283–94.
   PubMed Web of Science ®Google Scholar
• Sherwani MA, Tufail S, Khan AA, Owais M. (2015). Dendrimer-PLGA based multifunctional immuno-nanocomposite mediated synchronous and tumor selective delivery of siRNA and cisplatin: potential in treatment of hepatocellular carcinoma. RSC Adv 5:39512–31.
   Web of Science ®Google Scholar
• Shi S, Chen F, Ehlerding EB, Cai W. (2014). Surface engineering of graphene-based nanomaterials for biomedical applications. Bioconjug Chem 25:1609–19.
   PubMed Web of Science ®Google Scholar
• Subarkhan MKM, Ramesh R. (2016). Ruthenium(ii) arene complexes containing benzhydrazone ligands: synthesis, structure and antiproliferative activity. Inorg Chem Front 3:1245–55.
   Web of Science ®Google Scholar
• Sun T, Han J, Liu S, et al. (2019). Tailor-made semiconducting polymers for second near-infrared photothermal therapy of orthotopic liver cancer. ACS Nano 13:7345–54.
   PubMed Web of Science ®Google Scholar
• Tade RS, Patil PO. (2020). Theranostic prospects of graphene quantum dots in breast cancer. ACS Biomater Sci Eng 6:5987–6008.
   PubMed Web of Science ®Google Scholar
• van Breugel JMM, Geschwind J-F, Mirpour S, et al. (2019). Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model. Theranostics 9:3674–86.
   PubMed Web of Science ®Google Scholar
• Wang W, Dong X, Liu Y, et al. (2020). Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways. Biomed Pharmacother 131:110661.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chang Z, Lu M, et al. (2017). Janus silver/silica nanoplatforms for light-activated liver cancer chemo/photothermal therapy. ACS Appl Mater Interfaces 9:30306–17.
   PubMed Web of Science ®Google Scholar
• Wei X, Li P, Zhou H, et al. (2021). Engineering of gemcitabine coated nano-graphene oxide sheets for efficient near-infrared radiation mediated in vivo lung cancer photothermal therapy. J Photochem Photobiol B 216:112125.
   PubMed Web of Science ®Google Scholar
• Wo F, Xu R, Shao Y, et al. (2016). A multimodal system with synergistic effects of magneto-mechanical, photothermal, photodynamic and chemo therapies of cancer in graphene-quantum dot-coated hollow magnetic nanospheres. Theranostics 6:485–500.
   PubMed Web of Science ®Google Scholar
• Xia Y, Tang G, Chen Y, et al. (2021). Tumor-targeted delivery of siRNA to silence Sox2 gene expression enhances therapeutic response in hepatocellular carcinoma. Bioact Mater 6:1330–40.
   PubMed Web of Science ®Google Scholar
• Yang K, Feng L, Shi X, Liu Z. (2013). Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev 42:530–47.
   PubMed Web of Science ®Google Scholar
• Yang L, Tseng Y-T, Suo G, et al. (2015). Photothermal therapeutic response of cancer cells to aptamer-gold nanoparticle-hybridized graphene oxide under NIR illumination. ACS Appl Mater Interfaces 7:5097–106.
   PubMed Web of Science ®Google Scholar
• Yin F, Hu K, Chen Y, et al. (2017). SiRNA delivery with PEGylated graphene oxide nanosheets for combined photothermal and genetherapy for pancreatic cancer. Theranostics 7:1133–48.
   PubMed Web of Science ®Google Scholar
• Yin M, Zhou J, Gorak EJ, Quddus F. (2013). Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis. Oncologist 18:1248–55.
   PubMed Web of Science ®Google Scholar
• Yin Y, Li X, Ma H, et al. (2021). In situ transforming RNA nanovaccines from polyethylenimine functionalized graphene oxide hydrogel for durable cancer immunotherapy. Nano Lett 21:2224–31.
   PubMed Web of Science ®Google Scholar
• Zhang L, Sheng Y, Zehtab Yazdi A, et al. (2019). Surface-assisted assembly of a histidine-rich lipidated peptide for simultaneous exfoliation of graphite and functionalization of graphene nanosheets. Nanoscale 11:2999–3012.
   PubMed Web of Science ®Google Scholar
• Zhao M, Bu Y, Feng J, et al. (2020). SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancer. Cancer Lett 470:54–63.
   PubMed Web of Science ®Google Scholar
• Zheng L, Yang W, Wu F, et al. (2013). Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma. Clin Cancer Res 19:5372–80.
   PubMed Web of Science ®Google Scholar